Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 09-2004 | 09-2003 | 09-2002 | 09-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,715 | -4,495 | 867 | -1,706 | -3,829 |
| Depreciation Amortization | 433 | 420 | 206 | 88 | 261 |
| Accounts receivable | 50 | 317 | -161 | 113 | 322 |
| Other Working Capital | -54 | -2,194 | -3,908 | -4,255 | -497 |
| Other Operating Activity | 291 | -273 | -1,936 | 1,600 | 277 |
| Operating Cash Flow | $-11,995 | $-6,226 | $-4,932 | $-4,160 | $-3,466 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,839 | -9,924 | 10,803 | 995 | -626 |
| PPE Investments | -401 | -202 | -167 | 11 | -20 |
| Purchase Of Investment | -12,765 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 762 | -66 | -64 | 171 |
| Investing Cash Flow | $-3,327 | $-9,364 | $10,570 | $942 | $-475 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,263 | 1,080 | 9,705 | 34 | 15 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -453 |
| Financing Cash Flow | $17,263 | $1,080 | $9,705 | $34 | $-438 |
| Beginning Cash Position | 9,391 | 23,901 | 8,558 | 11,742 | 16,121 |
| End Cash Position | 11,332 | 9,391 | 23,901 | 8,558 | 11,742 |
| Net Cash Flow | $1,941 | $-14,510 | $15,343 | $-3,184 | $-4,379 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,995 | -6,226 | -4,932 | -4,160 | -3,466 |
| Capital Expenditure | -401 | -202 | -167 | -37 | -81 |
| Free Cash Flow | -12,396 | -6,427 | -5,099 | -4,197 | -3,547 |